Although it is traditionally understood as a disease arising from various combinations of diet, obesity, smoking, poor physical fitness, and family history, research also finds increased risk of CVD from a wide variety of environmental exposures.1
Types of Cardiovascular Disease
The term cardiovascular disease includes diseases involving the heart and circulatory system. Some of the most common forms of CVD include:
Coronary artery disease or CAD, also known as atherosclerotic heart disease, is the most common type of heart disease in the United States and can lead to heart attacks. The condition is caused by plaque buildup (atherosclerosis) in the lining of arteries that supply blood to the heart.
Heart attacks, also called myocardial infarctions, occur when blood flow to part of the heart muscle is insufficient, usually due to a blood clot or ruptured plaque. Coronary artery disease is the main cause of heart attacks; however, a severe spasm or sudden contraction of a coronary artery can also stop blood flow to the heart muscle.
High blood pressure, also called hypertension, is characterized by blood flowing through blood vessels at higher than normal pressures. About one in three US adults have high blood pressure.2
Low blood pressure, also called hypotension, can also be a symptom of cardiovascular diseases such as heart failure, heart attack and valve problems.
Cerebrovascular disease is most commonly caused by plaque buildup in arteries supplying blood to the brain. Strokes occur when blood does not flow properly to the brain, injuring brain tissue. This can result from a clot that blocks the flow of blood (called an ischemic stroke) or a rupture of a blood vessel in the brain, leading to bleeding (called a hemorrhagic stroke). Each year, 795,000 people in the US are estimated to suffer strokes, and roughly 130,000 will die of the event.3
Heart failure occurs when the heart is unable to pump a sufficient supply of oxygen-rich blood to the body. Due to weakening or stiffening of the heart muscle, heart failure can result from coronary artery disease, high blood pressure, or abnormalities of heart valves or muscle. About 5.8 million people in the United States have heart failure, and about half of those who develop heart failure will die within five years of diagnosis.4
Congenital heart defects are not included here but are discussed on our Birth Defects page.
Prevalence and Costs of Cardiovascular Disease
CVDs are the leading cause of death globally. The burden is not limited to high-income countries, as over three quarters of CVD deaths occur in low- and middle-income countries.5
Leading Causes of Death Globally

In most years, ischemic heart disease and stroke are the top two causes of death globally. In 2021, COVID-19 caused more deaths than stroke.7 Ischemic heart disease is a term for various heart problems caused by narrowing coronary arteries, such as CAD.8

In the United States, CVD is the leading cause of death, accounting for over 900,000 deaths in 2021.12 CVD causes almost one in five deaths—a rate still slightly above the cancer mortality rate.13

Source: CDC.14
Trends in Cardiovascular Disease
Rates of CVD are increasing worldwide. One reason for this rise is low- and middle-income countries' success in preventing and treating communicable diseases such as malaria and influenza. Because risk for CVD increases as we age, rates rise as people live longer. However, other factors also contribute to rising rates, such as increasing rates of smoking, physical inactivity, poor diet, and hypertension—all known CVD risk factors.15
In high-income countries, deaths from cardiovascular disease have been falling for decades. A 2015 study surmised that recent declines in CVD rates in high-income countries "are probably due to the combined effect of birth cohorts' decreased exposure to tobacco smoking, improvements in diet, and improved treatment of cardiovascular disease and cardiometabolic risk factors targeting the prevention of cardiovascular disease, and improved treatment of cardiovascular disease."16
In the United States, mortality rates peaked in the 1950s and 1960s and since then have fallen. Age-adjusted mortality decreased 30 percent for heart disease and 36 percent for stroke from 2000 to 2010, but the declines in these rates slowed after 2011.17 Mortality increased again after 2019. This is likely a consequence of direct and indirect effects of the COVID-19 pandemic. The increase persisted into 2022, the most recent year for which data are available.18
Age-Adjusted Heart Disease Death Rate, United States, 2000–2019.

Source: NCHS.19
Several factors have contributed to the decrease in cardiovascular mortality in the US:20
- Improvements to medical treatment of CVD and its precursors
- Better management of blood pressure and cholesterol
- Lower rates of smoking
- Improved physical activity
Costs of Cardiovascular Disease
A 2010 report by the Harvard School of Public Health estimated that CVD worldwide was responsible for $863 billion in costs per year from medical costs and loss of life-years and productivity. The authors of that report projected that these costs could rise to $1.044 trillion ($1,044,000,000,000) by 2030.21
Environmental Drivers of CVD
This table summarizes various lifestyle, medical, and toxicant exposure risk factors for cardiovascular disease, many of which are discussed in more detail following the table. References for lifestyle and medical risk factors are included in the discussions below. All toxicant listings are from CHE's Toxicant and Disease Database except as noted.
Disease or Condition |
Lifestyle / Medical Risk Factors |
Toxicants |
|
Strong Evidence* |
Good Evidence* |
||
Arrhythmias |
|
|
|
Cardiomyopathy |
|
|
|
Coronary artery disease, peripheral vascular disease, atherosclerosis |
|
|
|
Heart attack (myocardial infarction) |
|
|
|
Heart failure |
|
|
|
High blood pressure (hypertension) |
|
|
|
Stroke (cerebrovascular disease) |
|
|
|
*"Strong evidence" and "good evidence" are described on our About the Toxicant and Disease Database webpage.
While evidence indicates that individually modifiable lifestyle factors (high blood pressure, diet, physical activity and tobacco smoke) are more significant than chemical exposures in increasing CVD risk,37 a 2016 report from the World Health Organization estimated that 35 percent of the global burden of ischemic heart disease in disability-adjusted life years lost (DALYs) are attributable to environmental exposures, especially these:38
- Indoor and outdoor air pollution
- Secondhand tobacco smoke
- Lead
One DALY represents the loss of the equivalent of one year of full health. DALYs for a disease or health condition are the sum of the years of life lost to due to premature mortality (YLLs) and the years lived with a disability (YLDs) due to prevalent cases of the disease or health condition in a population; see Disability-adjusted life years (DALYs). WHO’s report also concluded that 42 percent of stroke-related DALYs are attributable to the environment, primarily indoor and outdoor air pollution (including ozone and secondhand tobacco smoke); lead; job strain; chemicals such as PCBs, dioxins, phthalates and pesticides; and radiation.39 Clearly, environmental exposures are significant contributors to CVD.
Air Pollution
Particulate matter pollution — from combustion (burning of wood, fossil fuels and other materials), mining, dust, and other sources, and often in combination with gases such as nitrogen dioxide and carbon monoxide — is a primary environmental contributor to cardiovascular disease risk.40 Particulates are a hazard both indoors and outdoors. Research has found that exposure to increased concentrations of particulate matter over a few hours to weeks can trigger cardiovascular disease-related heart attacks and death. Longer-term exposure also increased risk of cardiovascular mortality and decreases in life expectancy.41 See our Environmental Hazards pages for information on sources of pollution.
A 2014 report from the World Health Organization on air pollution estimated that globally seven million deaths were associated with both indoor and outdoor air pollution in 2012, with the majority of those coming from cardiovascular disease, primarily ischemic heart disease and stroke.42 Fine particle pollution has been associated with risk of ischemic heart disease, arrhythmias, heart failure, and cardiac arrest, in addition to overall cardiovascular mortality.43 Exposure to ambient air pollution can reduce life expectancy up to several years and was responsible for approximately 24 percent of the global burden of ischemic heart disease (in disability-adjusted life years) in 2012.44
Exposure to pollution appears to increase both the immediate and longer-term risks of cardiovascular events. Studies suggest that air pollution can activate inflammatory pathways—leading to atherosclerosis—and interfere with heart rhythm.45
Secondhand Smoke and Indoor Smoke
Secondhand smoke, or environmental tobacco smoke (ETS), can influence the cardiovascular system in several ways: increasing inflammation, insulin resistance and arterial resistance, and decreasing HDL cholesterol (“good” cholesterol) levels.46 ETS can also increase platelet aggregation, increasing the risk of blood clots.47
Although secondhand smoke may seem less serious than active smoking, effects are seen even at these lower exposure levels.48 Aggregated results of dozens of studies looking at the effects of secondhand smoke on cardiovascular disease show an increased risk of stroke of roughly 23 percent49 and an increased risk of heart disease between 25 and 30 percent.50
Other sources of smoke in indoor air, such as cooking stoves and wood stoves, also contribute to cardiovascular disease risk, with indoor cooking stoves a substantial contributor in developing countries.51
Lead
Lead poisoning is associated with an increased risk of cardiovascular disease risk, with several studies showing a small but significant rise of hypertension after lead exposure.52 Lead exposure has also been associated with a significant increase in CVD mortality, myocardial infarction (heart attack), stroke, ischemic heart disease, and atherosclerosis.53 The World Health Organization estimates that lead exposure was responsible for over 800,000 deaths from CVD in 2019.54
Other Environmental Drivers
Other exposures that also contribute to risk include arsenic, persistent organic pollutants, noise, stress, the design of the built environment, and extreme temperatures.
Arsenic
Long-term exposure to high levels of arsenic in drinking water has been associated with a thickening of small and medium-sized arteries in children and young adults and may increase the risk of CVD-related death, although evidence to date is not conclusive.55
Cadmium
Some evidence indicates that much of the increased risk of peripheral arterial disease arising from smoking results from exposure to cadmium in cigarettes.56 A 2013 review of the health effects of cadmium exposure showed elevated risks of cardiovascular disease, coronary heart disease, stroke, and peripheral artery disease.57 Evidence suggests that cadmium may act to increase CVD risk through atherosclerosis, initiating the buildup of plaques in the arteries.58
Lifestyle Factors
Lifestyle factors are the most important individually modifiable risk factors for CVD. These include an unhealthy diet, physical inactivity, and tobacco and alcohol use. Others, including stress and infectious disease, can also be important risk factors.
Nutrition

Nutrition is among the most important factors influencing heart health. Diet not only influences weight and obesity but can have strong impacts on insulin sensitivity and diabetes, inflammation throughout the body, low-density lipoprotein (LDL) levels, and oxidative stress, among others.60 While new research on dietary health is ongoing, and recommendations continue to evolve, researchers have enough understanding of how most foods can improve or impair cardiovascular health to provide evidence-based advice.
Dietary choices are not only due to individual preferences but are promoted or restricted by environmental and societal factors:
- Foods high in fat and sugar are often cheaper or more readily prepared than vegetables and whole grains. This is in part because current agricultural policies promote the production of refined grains and foods that are highly processed, sugary, and contain unhealthy fats, rather than healthier choices such as vegetables and fruits.
- The availability and affordability of fresh fruits and vegetables can vary widely by neighborhood, influenced by socioeconomic status and ethnicity. The existence of "food deserts" with limited or no access to fresh food limits neighborhood access to nutritious choices.61 See our Agriculture, Food, & Soil webpage for more information on both agricultural policy and food availability.
- The ability of individuals to pay for sufficient and nutritious food is influenced by economic systems where they live. Research has shown that people living with food insecurity – limited access to nutritious food – have an increased risk of cardiovascular morbidity and mortality.62
- Advertisements and cultural influences can also shift people towards or away from particular foods.
Physical Inactivity
Physical inactivity is one of the leading preventable risk factors for high blood pressure.63 Physical inactivity is also associated with a 24% increase in risk of coronary heart disease and a 16% increase in risk of stroke.64
Tobacco Smoking/Vaping
Tobacco smoking is well established as a contributor to cardiovascular disease risk. Smoking-induced cardiac damage comes from two major mechanisms: direct adverse effects on the myocardium and indirect effects on the myocardium through comorbidities such as atherosclerotic plaques in coronary arteries and hypertension that eventually damage and remodel the heart.65
The use of e-cigarettes (vaping) has been shown to have similar risks to cardiovascular health.66
Alcohol Consumption
Whether light or moderate alcohol consumption may have modest beneficial effects regarding ischemic heart disease and ischemic stroke is open to debate. But, occasions of heavy drinking—both sporadic and chronic—clearly increase the risk of most major cardiovascular disease categories.67
Other CVD Risk Factors
Infectious Disease
Well established links exist between CVD and some infectious diseases, possibly because systemic inflammation seen in infections can have damaging effects on blood vessels and the heart, increasing the risk for heart disease later in life:
- Periodontal disease—an infection of the gum tissue often precipitated by poor oral hygiene—has been associated with cardiovascular disease, although it is not clear whether the infection causes CVD itself.68
- Inflammation throughout the body as seen in herpes simplex 1 and Chlamydia pneumoniae may increase risk for cardiovascular disease.69
- People living with human immunodeficiency virus (HIV) have a greater risk of CVD.70
- COVID-19 is known to increase the risk of heart attack and stroke for up to a year after infection.71
Stress
The body’s normal stress response can include increases in blood pressure, heart rate, and blood glucose. When the stressor passes or is resolved, the body should return to its previous state. With repeated or chronic stress, the body’s ability to regulate the stress response is impaired. Chronic stress can lead to a greater risk of developing high blood pressure, atherosclerosis, myocardial infarction, and coronary heart disease.72 This process is explained in more detail on our Psychosocial Environment webpage.
Common contributors to chronic stress include:
- Poverty and socioeconomic stress
- Community violence and/or crime
- Household violence
- Housing instability
- Discrimination/perceived racism
- Work-related stresses
- Adverse childhood experiences
A 2006 study found that levels of stress hormones are significantly higher among those of lower socioeconomic status, independent of race and age. Perception of discrimination can also lead to chronic stress, associated with higher blood pressure among both adults and children.73
Comorbidities
Several comorbidities are important for assessing cardiovascular disease risk.
- People with diabetes develop cardiovascular disease at greater rates than those without diabetes, and those who develop cardiovascular disease tend to have poorer prognoses than those without diabetes.74
- Individuals with metabolic syndrome have a 53 percent increase in risk of developing CVD and 75 percent increase in risk of death from CVD.75
- High blood pressure can injure blood vessels, increasing the risk of stroke, atherosclerosis, and other cardiovascular diseases.76
- Kidney disease is both a cause and a consequence of cardiovascular disease. Risk of death from cardiovascular disease can be 10 to 30 times greater in dialysis patients compared to the regular population.77
Metabolic syndrome is a collection of conditions that sharply increase a person’s risk for cardiovascular disease, diabetes and stroke.78
People with three or more of the following conditions are considered to have metabolic syndrome:
- Abdominal obesity, as excess fat in the stomach area is a greater risk factor for heart disease than excess fat in other parts of the body, such as on the hips. A waistline of 40 inches or more in men or of 35 inches or more in women is considered a risk.
- Fasting blood glucose levels above 100mg/dL
- Elevated blood pressure, with either systolic blood pressure above 130 or diastolic blood pressure above 85.
- High levels of triglycerides in the blood, over 150mg/dL
- Low HDL cholesterol levels, below 40g/dL in women or below 50g/dL in men
Prevention and Policy
The risks and exposures related to cardiovascular diseases are interrelated and interconnected. For instance, a person’s race can influence exposure to microaggressions and discrimination that then cause stress. Access to education can influence social status, earning power, the ability to afford adequate housing and food, and more. These factors influence exposures and opportunities in the community, at workplace, in personal relationships, and in the home environment.
These factors can also contribute to personal choices that influence health. Addressing these interconnected factors individually, at any level, will contribute to CVD prevention. However, multilevel approaches will be more successful, as demonstrated in Finland’s North Karelia project. In the 1970s, N. Karelia had the highest cardiovascular mortality rates in the world, but population-based preventive measures through changes in lifestyle and the community environment dramatically reduced their incidence.79
Although cardiovascular disease is an enormous worldwide public health threat, opportunities to improve heart health and prevent CVD are available at the personal, community, national, and global levels.
Regional, National, and International Prevention
Cities, counties, states, and countries can influence cardiovascular health at the population level by promoting and enabling beneficial individual activities and by regulating harmful factors.
Promoting Healthier Diets
The structure of food production systems can promote healthier eating. Governmental subsidies, taxes, and regulations can have tremendous influence on the availability of both healthy choices (fresh fruits and vegetables) and unhealthy choices (refined grains and foods high in sugar and unhealthy fat; ultra-processed foods). Some examples of how policy influences food choices:
- In 2012, the US Department of Agriculture updated the minimum nutritional standards for the national school breakfast and lunch programs to align with current nutritional science regarding a healthy diet for children across different age groups.80
- Federal agricultural policies have contributed to dramatic changes in the US food supply since the 1930s, encouraging overproduction of commodity grain and oilseed crops such as corn and soybeans. Subsidies have fueled the rise of these calorie-dense crops in our food supply in the form of added fats and sugars, and their cheap availability as feed for livestock has contributed to an increase in less-healthy meat and dairy choices.81 Shifting subsidies and incentives toward more nutrient-dense food choices could bring the prices of these foods down and promote more healthy eating.
- The 2010 federal Affordable Care Act includes provisions requiring large retail food chains and vending machine operators to disclose calorie content of items on menus and in machines and also provide other important nutritional information.82
- Some localities have used zoning or licensing laws and incentive programs to regulate the location and density of fast food outlets or to promote the availability of healthy foods in neighborhood corner stores.83
- Cities, states, or federal agencies have set minimum nutrition standards for foods served in child care settings, regulated the use of trans fats, or taxed sugary beverages to decrease consumption rates.84 Early research shows that taxing unhealthy food choices reduces their consumption.85 In 2017 the US Food and Drug Administration banned trans fats specifically to reduce coronary heart disease and prevent thousands of fatal heart attacks every year.86
Encouraging Physical Activity
The design or retrofitting of buildings, neighborhoods, and transportation systems can encourage physical activity:
- The inclusion of safe, accessible stairways as an alternative to elevators, as well as other innovations in building design87
- Adding inviting parks, trails, and playgrounds to neighborhoods, and enhancing the safety and attractiveness of public walkways88
- Providing safe, convenient public transit89
- Building bicycle lanes or trails90
See more about how the built environment influences physical activity on our Built Environment webpage. Increasing active transportation at the population level can also provide extra benefits from reduced air pollution.
Decreasing Cigarette Smoking and Secondhand Smoke
The following policy actions, supported by the American Heart Association in a 2016 policy statement, are all associated with lower smoking rates in a population.91 These policies can also decrease exposure to secondhand smoke:92
- Bans on public and workplace smoking
- Tobacco excise taxes
- Funding for tobacco cessation and prevention programs
- Advocating for greater insurance coverage for smoking cessation programs
- Raising the minimum age for purchasing tobacco products
As of 2023, 35 states have adopted smoke-free laws for bars, restaurants, and worksites.93 A 2012 study aggregating the effects of many smoke-free policies throughout the US shows a 39 percent decrease in chest pain, coronary heart disease, and sudden cardiac death, as well as roughly 15 percent decrease in myocardial infarction, coronary syndrome, coronary events, ischemic heart disease, and stroke.94 A review done in 2023 found that smoke-free legislation was associated with approximately 9% to 10% reduced odds of overall CVD events.95
Discouraging Alcohol Use
Regulatory efforts to reduce excessive consumption of alcohol show promise in improving cardiovascular health.96
Reducing Air Pollution
In the US, National Ambient Air Quality Standards (NAAQS) were established with the 1990 Clean Air Act, with the primary goal of protecting public health, particularly for groups at greater risk, including children and the elderly. These standards are updated every five years to ensure they keep pace with our scientific understanding of the risks of air pollution. The American Heart Association supports full implementation of the Clean Air Act, tightening regulation of sources of air pollution, and other measures to reduce air pollution, both indoors and outdoors.97
The 2020 policy statement from the American Heart Association on air pollutants highlights the need for policies to reduce harmful exposures:
“Policy options to mitigate the adverse health impacts of air pollutants must include the reduction of emissions through action on air quality, vehicle emissions, and renewable portfolio standards, taking into account racial, ethnic, and economic inequality in air pollutant exposure. Policy interventions to improve air quality can also be in alignment with policies that benefit community and transportation infrastructure, sustainable food systems, reduction in climate forcing agents, and reduction in wildfires. The health care sector has a leadership role in adopting policies to contribute to improved environmental air quality as well.”98
Regulations to monitor and reduce air pollution have been extremely effective in decreasing CVD risk in the US. The US Environmental Protection Agency (EPA) estimated that over 230,000 deaths were prevented in 2020 because of Clean Air Act regulations of fine particulates and ozone.99
Reducing Chemical and Other Exposures
To date, typical discussions of prevention interventions focus heavily on lifestyle risk factors.100 However, addressing all contributors to cardiovascular disease risk, including harmful chemicals, pollutants, and other relevant exposures is necessary to prevent avoidable disease and death.
Policy initiatives to reduce hazardous chemical, radiation, noise, and other potentially harmful exposures could also reap cardiovascular benefits. UCSF’s Program on Reproductive Health and the Environment recently published recommendations to protect people and communities from harmful chemicals. Following these recommendations would strengthen our systems of chemical regulation and help prevent CVD as well as other conditions.
Personal Prevention
The systemic changes outlined above are necessary for more comprehensive prevention of CVD, but there are actions that individuals can take now to reduce their personal risk.
Choosing Healthier Diets
Because diet is among the most important determinants of CVD risk, CVD-prevention efforts must address dietary choices. Particularly effective is a diet with a variety of fruits, vegetables, unsaturated vegetable oils, whole grains, nuts, beans, and fish that are low in mercury and other contaminants.101 A heart-healthy diet is also low in sugars, red and processed meats, and refined grains. The American Heart Association publishes diet and lifestyle recommendations.
Research has revealed that focusing on a single aspect of diet—such as “low-fat” or “low-carb” options—does not produce much benefit to cardiovascular health. Not all fats have the same effect on CVD risk, and not all carbohydrates influence health equally. Focusing on the whole diet is more productive.102
The PREDIMED trial in 2013 was conducted among participants at high risk of CVD because of diabetes and/or additional risk factors but without known heart disease at the time of enrollment. Some participants were advised to follow a Mediterranean diet featuring fish, vegetables, fruit, white meats and given extra virgin olive oil (EVOO) and nuts as well.
Control participants were advised to consume a low fat diet without other restrictions. Those participants following the Mediterranean diet plus EVOO and nuts saw nearly 30 percent fewer major cardiovascular events when compared to participants following a low-fat diet after an average follow-up period of 4.8 years.103 Other dietary patterns are also effective for promoting heart health.104 There is general agreement that diets high in sugar, sodium, refined grains, and industrial trans fats, while low in fruits, vegetables, legumes, and whole grains are harmful to cardiovascular health, increasing the risk of heart disease and stroke.105
Purchasing organic fruits and vegetables when possible can help reduce exposure to pesticides, many of which are associated with various health harms.
Increasing Physical Activity
Just 30 minutes of walking per day is associated with a lower risk of coronary heart disease, stroke, and overall cardiovascular disease.106 The World Health Organization, Centers for Disease Control, and the American Heart Association all recommend these levels of physical activity at a minimum each week for adults 18-64:107
- 150 minutes of moderate-intensity aerobic activity, or 75 minutes of vigorous-intensity aerobic activity, or some comparable combination of these.
- Two muscle-strengthening activities that work all major muscle groups (legs, hips, back, abdomen, chest, shoulders, and arms).
These guidelines are adjusted for children, for older adults, and for pregnant and postpartum women. Please see the CDC guidelines for more information.
Eliminating Cigarette Smoking and Reducing Alcohol Use
Well-established data show that refraining from smoking and exposures to secondhand smoke will reduce lifetime risk of CVD. Because exposures can start before birth and continue throughout childhood, families and entire households—and not just individuals—need to address cigarette smoking at home.108 Eliminating excessive alcohol consumption, even just occasional heavy drinking, also reduces risk. The American Heart Association does not recommend any alcohol consumption.109
Avoiding Chemicals and Other Exposures
Reducing personal exposures to noise, air pollution, and chemicals listed in the table above will reduce CVD risk. More information about sources of exposure and avoiding those exposures is published on our related webpages, available through the links in the table.
Prevention and Lifetime Risk of CVD
The concept of the Developmental Origins of Health and Disease (DOHaD) outlines the important role played by environmental exposures and nutrition during pregnancy and early childhood. Underlying DOHaD is the idea that environmental exposures in utero or early in a child's life can have wide-ranging and long-term effects on cardiovascular health in adulthood.
Other factors, such as chronic stress, or other adverse child experiences, such as housing instability, childhood maltreatment, or regular discrimination can also increase the risk of CVD beginning in early adulthood and continuing throughout the lifecourse.110 This all indicates the inadequacy of treating CVD exclusively in adults, only after they are at high risk for the disease or have been diagnosed. Resources could be effectively aimed at decreasing childhood exposure to CVD risk factors early in life, rather than simply treating the disease after it arises.

Created by Nancy Hepp and Tom Austin from several sources.111
For more information, explore our CVD-related webinars.
This page was last revised in June 2024 by CHE’s Science Writer Matt Lilley, with input from Ted Schettler, MD, MPH, and editing support from CHE Director Kristin Schafer.
CHE invites our partners to submit corrections and clarifications to this page. Please include links to research to support your submissions through the comment form on our Contact page.
- World Health Organization. The top 10 causes of death. December 2020. Viewed June 07, 2024; National Center for Health Statistics. Leading Causes of Death. Centers for Disease Control and Prevention. May 02, 2024. Viewed June 07, 2024. World Health Organization. Cardiovascular diseases (CVDs). June 2021. Viewed June 07, 2024.
- Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Rodger VL. Epidemiology of heart failure. Circulation Research. 2013 Aug 30;113(6):646–659.
- World Health Organization. Cardiovascular diseases (CVDs). June 2021. Viewed June 07, 2024.
- World Health Organization. The top 10 causes of death. August 2024. Viewed August 13, 2024.
- World Health Organization. The top 10 causes of death. August 2024. Viewed August 13, 2024.
- Institute of Medicine (US) Committee on Social Security Cardiovascular Disability Criteria. Cardiovascular Disability: Updating the Social Security Listings. 7, Ischemic Heart Disease. Washington (DC): National Academies Press (US); 2010.
- University of Washington Institute for Health Metrics and Evaluation. Global Health Data Exchange. Viewed June 07, 2024.
- World Health Organization. Metrics: Disability-Adjusted Life Year (DALY). Viewed June 07, 2024.
- Martin SS et al; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. January 24, 2024; National Center for Health Statistics. Leading Causes of Death. Centers for Disease Control and Prevention. May 02, 2024. Viewed June 10, 2024.
- Centers for Disease Control and Prevention. Heart Disease Facts. May 15, 2024. Viewed June 10, 2024.
- Centers for Disease Control and Prevention. Heart Disease Facts. May 15, 2024. Viewed June 10, 2024.
- Roth GA, Forouzanfar MH et al. Demographic and epidemiologic drivers of global cardiovascular mortality. New England Journal of Medicine. 2015 Apr 2;372(14):1333-41; Dattani S et al. Cardiovascular Diseases. Our World in Data. 2023. Viewed June 10, 2024.
- Roth GA, Forouzanfar MH et al. Demographic and epidemiologic drivers of global cardiovascular mortality. New England Journal of Medicine. 2015 Apr 2;372(14):1333-41.
- Sidney S, Quesenberry CP et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiology. 2016;1(5):594-599.
- Sidney S, Quesenberry CP et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiology. 2016;1(5):594-599; Woodruff RC et al. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022. American Journal of Preventive Medicine. 2024;66(4):582-589; Centers for Disease Control and Prevention. Heart Disease Prevalence. June 26, 2023. Viewed June 10, 2024.
- Sawyer A, Flagg LA. State declines in heart disease mortality in the United States, 2000–2019. NCHS Data Brief, no 425. Hyattsville, MD: National Center for Health Statistics. 2021. Viewed June 10, 2024.
- Ford ES, Ajani UA et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. New England Journal of Medicine. 2007 Jun 7;356(23):2388-98; Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Song X, Liu Y et al. Short-term exposure to air pollution and cardiac arrhythmia: a meta-analysis and systematic review. International Journal of Environmental Research and Public Health. 2016 Jun 28;13(7). pii: E642; Kowalska M, Kocot K. Short-term exposure to ambient fine particulate matter (PM2,5 and PM10) and the risk of heart rhythm abnormalities and stroke. Postepy Higieny i Medycyny Doswiadczalnej. 2016 Sep 28;70(0):1017-1025; Shao Q , Liu T, Korantzopoulos P, Zhang Z, Zhao J, Li G. Association between air pollution and development of atrial fibrillation: a meta-analysis of observational studies. Heart & Lung. 2016 Nov - Dec;45(6):557-562; He F et al. Acute Impact of Fine Particulate Air Pollution on Cardiac Arrhythmias in a Population‐Based Sample of Adolescents: The Penn State Child Cohort. Journal of the American Heart Association. 2022 Sep 20;11(18); Bennett M et al. Air Pollution and Arrhythmias. Canadian Journal of Cardiology. 2023; 39(9):1253-1262.
- Kokubo Y, Matsumoto C. Traditional cardiovascular risk factors for incident atrial fibrillation. Circulation Journal. 2016 Nov 25;80(12):2415-2422.
- Centers for Disease Control and Prevention. About Cardiomyopathy. May 15, 2024. Viewed June 10, 2024.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Williamson L. Air pollution exposure may cause heart attack within an hour. American Heart Association News. April 22, 2022. Viewed June 10, 2024.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Shah ASV, Langrish JP et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013 Sep 21; 382(9897): 1039–1048; Pope CA 3rd, Burnett RT et al. Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation. 2004 Jan 6;109(1):71-7.
- Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environmental Research. 2010 Feb;110(2):199-206; Tellez-Plaza M1 Guallar E at al. Cadmium exposure and incident cardiovascular disease. Epidemiology. 2013 May;24(3):421-9; Borné Y, Barregard L et al. Cadmium exposure and incidence of heart failure and atrial fibrillation: a population-based prospective cohort study. BMJ Open. 2015; 5(6): e007366.
- Brook RD. The environment and blood pressure. Cardiology Clinics. 2017 May;35(2):213-221; Meng X, Zhang Y, Yang KQ, Yang YK, Zhou XL. Potential harmful effects of PM2.5 on occurrence and progression of acute coronary syndrome: epidemiology, mechanisms, and prevention measures. International Journal of Environmental Research and Public Health. 2016 Jul 25;13(8). pii: E748.
- Genchi G, Sinicropi MS, Carocci A, Lauria G, Catalano A. Mercury exposure and heart diseases. International Journal of Environmental Research and Public Health. 2017 Jan 12;14(1). pii: E74.
- Han C, Hong YC. Bisphenol A, hypertension, and cardiovascular diseases: epidemiological, laboratory, and clinical trial evidence. Current Hypertension Reports. 2016 Feb;18(2):11; Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. Journal of Environmental and Public Health. 2012;2012:481641; Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Perkins JT, Petriello MC, Newsome BJ, Hennig B. Polychlorinated biphenyls and links to cardiovascular disease. Environmental Science and Pollution Research International. 2016 Feb;23(3):2160-72; Goncharov A, Pavuk M, Foushee HR, Carpenter DO; Anniston Environmental Health Research Consortium. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environmental Health Perspectives. 2011 Mar;119(3):319-25; Lind PM, Penell J, Salihovic S, van Bavel B, Lind L. Circulating levels of p,p'-DDE are related to prevalent hypertension in the elderly. Environmental Research. 2014 Feb;129:27-31.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Pencina MJ, Navar AM, Wojdyla D, et al. Quantifying Importance of Major Risk Factors for Coronary Heart Disease. Circulation. 2019;139(13):1603-1611.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- US Environmental Protection Agency. Air Pollution and Cardiovascular Disease Basics. May 22, 2024. Viewed June 10, 2024.
- World Health Organization. 7 million premature deaths annually linked to air pollution. WHO Media Center. March 25, 2014. Viewed June 10, 2024.
- Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six US cities. Environmental Health Perspectives. 2000 Oct; 108(10): 941–947; Fatmi Z, Coggon D2. Coronary heart disease and household air pollution from use of solid fuel: a systematic review. British Medical Bulletin. 2016 Jun;118(1):91-109.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004 Jan 6;109(1):71-7; Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circulation Research. 2006 Sep 29;99(7):692-705; Brook RD, Rajagopalan S et al, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78.
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- DiGiacomo SI, Jazayeri MA, Barua RS, Ambrose JA. Environmental Tobacco Smoke and Cardiovascular Disease. Int J Environ Res Public Health. 2018;16(1):96.
- Argacha JF, Bourdrel T, van de Borne P. Ecology of the cardiovascular system: a focus on air-related environmental factors. Trends in Cardiovascular Medicine. 2017 Aug 4. pii: S1050-1738(17)30117-2. As exposure time increases, risks quickly approach those of smokers.Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- Lee PN, Thornton AJ, Forey BA, Hamling JS. Environmental tobacco smoke exposure and risk of stroke in never smokers: an updated review with meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 2017 Jan;26(1):204-216.
- Institute of Medicine (US) Committee on Secondhand Smoke Exposure and Acute Coronary Events. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: National Academies Press (US); 2010.
- Argacha JF, Bourdrel T, van de Borne P. Ecology of the cardiovascular system: a focus on air-related environmental factors. Trends in Cardiovascular Medicine. 2017 Aug 4. pii: S1050-1738(17)30117-2.
- Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. American Journal of Epidemiology. 1985 Feb;121(2):246-58.
- Solenkova NV, Newman JD, Berger JS, Thurston G, Hochman JS, Lamas GA. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. American Heart Journal. 2014 Dec;168(6):812-22.
- World Health Organization. The Public Health Impact of Chemicals: Knowns and Unknowns: Data addendum for 2019. 2021.
- Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. American Journal of Epidemiology. 2005 Dec 1;162(11):1037-49; States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci. 2009;107(2):312-323.
- Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 Jun 29;109(25):3196-201.
- Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A. Cadmium exposure and clinical cardiovascular disease: a systematic review. Current Atherosclerosis Reports. 2013 Oct;15(10):356.
- Messner B, Knoflach M et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arteriosclerosis, Thrombosis, and Vasccular Biology. 2009 Sep;29(9):1392-8.
- Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016 Jan 12;133(2):187-225.
- Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016 Jan 12;133(2):187-225.
- Hilmers A, Hilmers DC, Dave J. Neighborhood disparities in access to healthy foods and their effects on environmental justice. American Journal of Public Health. 2012 Sep;102(9):1644-54.
- Chang R, Javed Z, Taha M, et al. Food insecurity and cardiovascular disease: Current trends and future directions. Am J Prev Cardiol. 2021;9:100303.
- Centers for Disease Control and Prevention. High Blood Pressure Risk Factors. May 14, 2024. Viewed June 10, 2024.
- Kivimäki M, Singh-Manoux A, Pentti J, et al. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. BMJ. 2019;365:l1495.
- Kaplan A, Abidi E, Ghali R, Booz GW, Kobeissy F, Zouein FA. Functional, cellular, and molecular remodeling of the heart under influence of oxidative cigarette tobacco smoke. Oxidative Medicine and Cellular Longevity. 2017;2017:3759186.
- National Institutes of Health. NIH-funded studies show damaging effects of vaping, smoking on blood vessels. October 26, 2022. Viewed June 10, 2024.
- Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends in Cardiovascular Medicine. 2017 Jun 10. pii: S1050-1738(17)30078-6; Zhou Y, Zheng J, Li S, Zhou T, Zhang P, Li HB. Alcoholic beverage consumption and chronic diseases. International Journal of Environmental Research and Public Health. 2016 May 24;13(6). pii: E522; Mukamal KJ, Rimm EB. Alcohol's effects on the risk for coronary heart disease. Alcohol Res Health. 2001;25(4):255-261; Gardner JD, Mouton AJ. Alcohol effects on cardiac function. Comprehensive Physiology. 2015 Apr;5(2):791-802.
- DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993 Mar 13;306(6879):688-91; Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. Journal of Periodontology. 1996 Oct;67(10 Suppl):1123-37.
- Siscovick DS, Schwartz SM et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation. 2000 Nov 7;102(19):2335-40.
- Chu C, Pollock LC, Selwyn PA. HIV-associated complications: a systems-based approach. American Family Physician. 2017 Aug 1;96(3):161-169; Ballocca F, D'Ascenzo F, Gili S, Grosso Marra W, Gaita F. Cardiovascular disease in patients with HIV. Trends in Cardiovascular Medicine. 2017 Jun 12. pii: S1050-1738(17)30089-0.
- Eberhardt N, Noval MG, Kaur R, et al. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Preprint. bioRxiv. 2023;2023.08.14.553245.
- Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research. 2002 Jan;52(1):1-23; Dimsdale JE. Psychological stress and cardiovascular disease. Journal of the American College of Cardiology. 2008 Apr 1; 51(13): 1237–1246; Bosma H, Peter R, Siegrist J, Marmot M. Two alternative job stress models and the risk of coronary heart disease. American Journal of Public Health. 1998 January; 88(1): 68–74.
- Cohen S, Doyle WJ, Baum A. Socioeconomic status is associated with stress hormones. Psychosomatic Medicine. 2006 May-Jun;68(3):414-20; Thomas KS, Nelesen RA, Ziegler MG, Bardwell WA, Dimsdale JE. Job strain, ethnicity, and sympathetic nervous system activity. Hypertension. 2004 Dec;44(6):891-6;Goosby BJ, Malone S, Richardson E, Cheadle JE, Williams D. Perceived discrimination and markers of cardiovascular risk among low-income African American youth. American Journal of Human Biology. 2015 Jul 8; 27(4): 546–552.
- Grundy SM, Benjamin et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999 Sep 7;100(10):1134-46.
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine. 2006 Oct;119(10):812-9.
- MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765-74.
- American Society of Nephrology. The Kidney and Heart Disease Connection. Viewed June 11, 2024.
- National Heart, Lung and Blood Institute. What Is Metabolic Syndrome? June 22, 2016. Viewed June 11, 2024.
- Vartiainen E. The North Karelia Project: Cardiovascular disease prevention in Finland. Glob Cardiol Sci Pract. 2018;2018(2):13.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Schoonover H. A Fair Farm Bill for Public Health. Institute for Agriculture and Trade Policy. May 2007.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Duffey KJ, Gordon-Larsen P et al. Food price and diet and health outcomes. Archives of Internal Medicine. 2010;170(5):420-426; Silver LD, Ng SW et al. Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: a before-and-after study. PLoS Medicine. 2017 Apr 18;14(4):e1002283.
- US Food and Drug Administration. FDA Cuts Trans Fat in Processed Foods. Marcy 17, 2017. Viewed August 25, 2017.
- Nicoll G, Zimring C. Effect of innovative building design on physical activity. Journal of Public Health Policy. 2009;30 Suppl 1:S111-23; Jancey JM, McGann S et al. Workplace building design and office-based workers' activity: a study of a natural experiment. Australian and New Zealand Journal of Public Health. 2016 Feb;40(1):78-82.
- Barnett DW, Barnett A et al. Built environmental correlates of older adults' total physical activity and walking: a systematic review and meta-analysis. International Journal of Behavorial Nutrition and Physical Activity. 2017 Aug 7;14(1):103; Bancroft C, Joshi S et al. Association of proximity and density of parks and objectively measured physical activity in the United States: a systematic review. Social Science and Medicine. 2015 Aug;138:22-30; Yen IH, Fandel Flood J, Thompson H, Anderson LA, Wong G. How design of places promotes or inhibits mobility of older adults: realist synthesis of 20 years of research. Journal of Aging and Health. 2014 Dec;26(8):1340-72.
- King DM, Jacobson SH. What is driving obesity? A review on the connections between obesity and motorized transportation. Current Obesity Reports. 2017 Mar;6(1):3-9; Yen IH, Fandel Flood J, Thompson H, Anderson LA, Wong G. How design of places promotes or inhibits mobility of older adults: realist synthesis of 20 years of research. Journal of Aging and Health. 2014 Dec;26(8):1340-72.
- Pucher J, Dill J, Handy S. Infrastructure, programs, and policies to increase bicycling: an international review. Preventive Medicine. 2010 Jan;50 Suppl 1:S106-25; Hirsch JA, Meyer KA et al. Municipal investment in off-road trails and changes in bicycle commuting in Minneapolis, Minnesota over 10 years: a longitudinal repeated cross-sectional study. International Journal of Behavioral Nutrition and Physical Activity. 2017 Feb 13;14(1):21.
- Labarthe DR, Goldstein LB et al. Evidence-based policy making: assessment of the American Heart Association's Strategic Policy Portfolio: a policy statement from the American Heart Association. Circulation. 2016 May 3;133(18):e615-53.
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- Centers for Disease Control and Prevention. STATE System Smokefree Indoor Air Fact Sheet. February 28, 2024. Viewed June 11, 2024.
- Tan CE, Glantz SA. Association between smokefree legislation and hospitalizations for cardiac, cerebrovascular and respiratory diseases: a meta-analysis. Circulation. 2012 Oct 30; 126(18): 2177–2183.
- Akter S, Islam MR, Rahman MM, et al. Evaluation of Population-Level Tobacco Control Interventions and Health Outcomes: A Systematic Review and Meta-Analysis. JAMA Network Open. 2023;6(7):e2322341.
- Parry CD, Patra J, Rehm J. Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction. 2011 Oct;106(10):1718-24.
- American Heart Association. Facts: Danger in the Air Air Pollution and Cardiovascular Disease. Viewed August 13, 2017.
- Tan CE, Glantz SA. Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association. Circulation. 2020 Nov 05; 142(23): e432–e447.
- US Environmental Protection Agency. Benefits and Costs of the Clean Air Act 1990-2020, the Second Prospective Study. May 15, 2024. Viewed June 11, 2024.
- Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; Fuster V, Kelly BB, editors. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington (DC): National Academies Press (US); 2010; World Health Organization. New initiative launched to tackle cardiovascular disease, the world's number one killer. September 22, 2016. Viewed August 29, 2017; De Backer G, Ambrosioni E et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). European Heart Journal. 2003 Sep;21(17):1601–10.
- US Food and Drug Administration. Advice about Eating Fish. March 05, 2024. Viewed June 11, 2024; Also see state-specific advisories.
- Tang G, Wang D, Long J, Yang F, Si L. Meta-analysis of the association between whole grain intake and coronary heart disease risk. American Journal of Cardiology. 2015 Mar 1;115(5):625-9; Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2014 Jul;100(1):278-88;Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutrition. 2012 Apr;15(4):725-37; Ravera A, Carubelli V et al. Nutrition and cardiovascular disease: finding the perfect recipe for cardiovascular health. Nutrients. 2016 Jun 14;8(6). pii: E363.
- Estruch R, Ros E et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine. 2013 Apr 4;368(14):1279-90.
- US Department of Agriculture. Dietary Patterns and Risk of Cardiovascular Disease. Viewed June 11, 2024.
- Li XY, Cai XL, Bian PD, Hu LR. High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS Neuroscience & Therapeutics. 2012 Aug;18(8):691-701; Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. New England Journal of Medicine. 2006 Apr 13;354(15):1601-13; Xi B, Huang Y, Reilly KH et al. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. British Journal of Nutrition. 2015 Mar 14;113(5):709-17.
- Carnethon MR. Physical activity and cardiovascular disease: how much is enough? American Journal of Lifestyle Medicine. 2009 Jul;3(1 Suppl):44S-49S; Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. American Journal of Preventive Medicine. 2004 Jun;26(5):407-18.
- World Health Organization. Global recommendations on physical activity for health. 2010. Viewed June 11, 2024; Centers for Disease Control and Prevention. Physical activity basics: How much physical activity do you need? March 26, 2024. Viewed June 11, 2024; American Heart Association. American Heart Association recommendations for physical activity in adults and kids. January 19, 2024. Viewed June 11, 2024.
- Brown N, Luckett T, Davidson PM, DiGiacomo M. Family-focussed interventions to reduce harm from smoking in primary school-aged children: a systematic review of evaluative studies. Preventive Medicine. 2017 Aug;101:117-125.
- American Heart Association. Is drinking alcohol part of a healthy lifestyle? December 30, 2019. Viewed June 11, 2024.
- Jackson DB, Testa A, Woodward KP, Qureshi F, Ganson KT, Nagata JM. Adverse Childhood Experiences and Cardiovascular Risk among Young Adults: Findings from the 2019 Behavioral Risk Factor Surveillance System. Int J Environ Res Public Health. 2022;19(18):11710.
- Berkman LF, Kawachi I, editors. Social Epidemiology. New York: Oxford University Press; 2000; Hardy R, Lawlor DA, Kuh D. A life course approach to cardiovascular aging. Future Cardiology. 2015;11(1):101-13; Aboderin I, Kalache A, Ben-Shlomo Y, Lynch JW, Yajnik CS, Kuh D, Yach D. Life course perspectives on coronary heart disease, stroke and diabetes: key issues and implications for policy and research. 2001 Geneva, World Health Organization. 2002; Halfon N, Larson K, Lu M, Tullis E, Russ S. Lifecourse health development: past, present and future. Maternal and Child Health Journal. 2014 Feb;18(2):344-65; Hanson MA, Cooper C, Aihie Sayer A, Eendebak RJ, Clough GF, Beard JR. Developmental aspects of a life course approach to healthy ageing. Journal of Physiology. 2016 Apr 15;594(8):2147-60.
- World Health Organization. The top 10 causes of death. December 2020. Viewed June 07, 2024; National Center for Health Statistics. Leading Causes of Death. Centers for Disease Control and Prevention. May 02, 2024. Viewed June 07, 2024. World Health Organization. Cardiovascular diseases (CVDs). June 2021. Viewed June 07, 2024.
- Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Rodger VL. Epidemiology of heart failure. Circulation Research. 2013 Aug 30;113(6):646–659.
- World Health Organization. Cardiovascular diseases (CVDs). June 2021. Viewed June 07, 2024.
- World Health Organization. The top 10 causes of death. August 2024. Viewed August 13, 2024.
- World Health Organization. The top 10 causes of death. August 2024. Viewed August 13, 2024.
- Institute of Medicine (US) Committee on Social Security Cardiovascular Disability Criteria. Cardiovascular Disability: Updating the Social Security Listings. 7, Ischemic Heart Disease. Washington (DC): National Academies Press (US); 2010.
- University of Washington Institute for Health Metrics and Evaluation. Global Health Data Exchange. Viewed June 07, 2024.
- World Health Organization. Metrics: Disability-Adjusted Life Year (DALY). Viewed June 07, 2024.
- Martin SS et al; on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. 2024 Heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. January 24, 2024; National Center for Health Statistics. Leading Causes of Death. Centers for Disease Control and Prevention. May 02, 2024. Viewed June 10, 2024.
- Centers for Disease Control and Prevention. Heart Disease Facts. May 15, 2024. Viewed June 10, 2024.
- Centers for Disease Control and Prevention. Heart Disease Facts. May 15, 2024. Viewed June 10, 2024.
- Roth GA, Forouzanfar MH et al. Demographic and epidemiologic drivers of global cardiovascular mortality. New England Journal of Medicine. 2015 Apr 2;372(14):1333-41; Dattani S et al. Cardiovascular Diseases. Our World in Data. 2023. Viewed June 10, 2024.
- Roth GA, Forouzanfar MH et al. Demographic and epidemiologic drivers of global cardiovascular mortality. New England Journal of Medicine. 2015 Apr 2;372(14):1333-41.
- Sidney S, Quesenberry CP et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiology. 2016;1(5):594-599.
- Sidney S, Quesenberry CP et al. Recent trends in cardiovascular mortality in the United States and public health goals. JAMA Cardiology. 2016;1(5):594-599; Woodruff RC et al. Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022. American Journal of Preventive Medicine. 2024;66(4):582-589; Centers for Disease Control and Prevention. Heart Disease Prevalence. June 26, 2023. Viewed June 10, 2024.
- Sawyer A, Flagg LA. State declines in heart disease mortality in the United States, 2000–2019. NCHS Data Brief, no 425. Hyattsville, MD: National Center for Health Statistics. 2021. Viewed June 10, 2024.
- Ford ES, Ajani UA et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. New England Journal of Medicine. 2007 Jun 7;356(23):2388-98; Mozaffarian D, Benjamin EJ, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016 Jan 26;133(4):e38-360.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Song X, Liu Y et al. Short-term exposure to air pollution and cardiac arrhythmia: a meta-analysis and systematic review. International Journal of Environmental Research and Public Health. 2016 Jun 28;13(7). pii: E642; Kowalska M, Kocot K. Short-term exposure to ambient fine particulate matter (PM2,5 and PM10) and the risk of heart rhythm abnormalities and stroke. Postepy Higieny i Medycyny Doswiadczalnej. 2016 Sep 28;70(0):1017-1025; Shao Q , Liu T, Korantzopoulos P, Zhang Z, Zhao J, Li G. Association between air pollution and development of atrial fibrillation: a meta-analysis of observational studies. Heart & Lung. 2016 Nov - Dec;45(6):557-562; He F et al. Acute Impact of Fine Particulate Air Pollution on Cardiac Arrhythmias in a Population‐Based Sample of Adolescents: The Penn State Child Cohort. Journal of the American Heart Association. 2022 Sep 20;11(18); Bennett M et al. Air Pollution and Arrhythmias. Canadian Journal of Cardiology. 2023; 39(9):1253-1262.
- Kokubo Y, Matsumoto C. Traditional cardiovascular risk factors for incident atrial fibrillation. Circulation Journal. 2016 Nov 25;80(12):2415-2422.
- Centers for Disease Control and Prevention. About Cardiomyopathy. May 15, 2024. Viewed June 10, 2024.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Williamson L. Air pollution exposure may cause heart attack within an hour. American Heart Association News. April 22, 2022. Viewed June 10, 2024.
- Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Shah ASV, Langrish JP et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet. 2013 Sep 21; 382(9897): 1039–1048; Pope CA 3rd, Burnett RT et al. Cardiovascular mortality and long-term exposure to particulate air pollution. Circulation. 2004 Jan 6;109(1):71-7.
- Peters JL, Perlstein TS, Perry MJ, McNeely E, Weuve J. Cadmium exposure in association with history of stroke and heart failure. Environmental Research. 2010 Feb;110(2):199-206; Tellez-Plaza M1 Guallar E at al. Cadmium exposure and incident cardiovascular disease. Epidemiology. 2013 May;24(3):421-9; Borné Y, Barregard L et al. Cadmium exposure and incidence of heart failure and atrial fibrillation: a population-based prospective cohort study. BMJ Open. 2015; 5(6): e007366.
- Brook RD. The environment and blood pressure. Cardiology Clinics. 2017 May;35(2):213-221; Meng X, Zhang Y, Yang KQ, Yang YK, Zhou XL. Potential harmful effects of PM2.5 on occurrence and progression of acute coronary syndrome: epidemiology, mechanisms, and prevention measures. International Journal of Environmental Research and Public Health. 2016 Jul 25;13(8). pii: E748.
- Genchi G, Sinicropi MS, Carocci A, Lauria G, Catalano A. Mercury exposure and heart diseases. International Journal of Environmental Research and Public Health. 2017 Jan 12;14(1). pii: E74.
- Han C, Hong YC. Bisphenol A, hypertension, and cardiovascular diseases: epidemiological, laboratory, and clinical trial evidence. Current Hypertension Reports. 2016 Feb;18(2):11; Shankar A, Teppala S. Urinary bisphenol A and hypertension in a multiethnic sample of US adults. Journal of Environmental and Public Health. 2012;2012:481641; Gao X, Wang HS. Impact of bisphenol A on the cardiovascular system—epidemiological and experimental evidence and molecular mechanisms. International Journal of Environmental Research and Public Health. 2014 Aug 15;11(8):8399-413.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Perkins JT, Petriello MC, Newsome BJ, Hennig B. Polychlorinated biphenyls and links to cardiovascular disease. Environmental Science and Pollution Research International. 2016 Feb;23(3):2160-72; Goncharov A, Pavuk M, Foushee HR, Carpenter DO; Anniston Environmental Health Research Consortium. Blood pressure in relation to concentrations of PCB congeners and chlorinated pesticides. Environmental Health Perspectives. 2011 Mar;119(3):319-25; Lind PM, Penell J, Salihovic S, van Bavel B, Lind L. Circulating levels of p,p'-DDE are related to prevalent hypertension in the elderly. Environmental Research. 2014 Feb;129:27-31.
- Münzel T, Gori T, Babisch W, Basner M. Cardiovascular effects of environmental noise exposure. European Heart Journal. 2014 Apr;35(13):829-36.
- Pencina MJ, Navar AM, Wojdyla D, et al. Quantifying Importance of Major Risk Factors for Coronary Heart Disease. Circulation. 2019;139(13):1603-1611.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- US Environmental Protection Agency. Air Pollution and Cardiovascular Disease Basics. May 22, 2024. Viewed June 10, 2024.
- World Health Organization. 7 million premature deaths annually linked to air pollution. WHO Media Center. March 25, 2014. Viewed June 10, 2024.
- Laden F, Neas LM, Dockery DW, Schwartz J. Association of fine particulate matter from different sources with daily mortality in six US cities. Environmental Health Perspectives. 2000 Oct; 108(10): 941–947; Fatmi Z, Coggon D2. Coronary heart disease and household air pollution from use of solid fuel: a systematic review. British Medical Bulletin. 2016 Jun;118(1):91-109.
- Prüss-Ustün A, Wolf J, Corvalán C, Bos R, Neira M. Preventing disease through healthy environments: A global assessment of the burden of disease from environmental risks. World Health Organization. 2016.
- Pope CA 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004 Jan 6;109(1):71-7; Bhatnagar A. Environmental cardiology: studying mechanistic links between pollution and heart disease. Circulation Research. 2006 Sep 29;99(7):692-705; Brook RD, Rajagopalan S et al, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010 Jun 1;121(21):2331-78.
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- DiGiacomo SI, Jazayeri MA, Barua RS, Ambrose JA. Environmental Tobacco Smoke and Cardiovascular Disease. Int J Environ Res Public Health. 2018;16(1):96.
- Argacha JF, Bourdrel T, van de Borne P. Ecology of the cardiovascular system: a focus on air-related environmental factors. Trends in Cardiovascular Medicine. 2017 Aug 4. pii: S1050-1738(17)30117-2. As exposure time increases, risks quickly approach those of smokers.Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- Lee PN, Thornton AJ, Forey BA, Hamling JS. Environmental tobacco smoke exposure and risk of stroke in never smokers: an updated review with meta-analysis. Journal of Stroke and Cerebrovascular Diseases. 2017 Jan;26(1):204-216.
- Institute of Medicine (US) Committee on Secondhand Smoke Exposure and Acute Coronary Events. Secondhand Smoke Exposure and Cardiovascular Effects: Making Sense of the Evidence. Washington, DC: National Academies Press (US); 2010.
- Argacha JF, Bourdrel T, van de Borne P. Ecology of the cardiovascular system: a focus on air-related environmental factors. Trends in Cardiovascular Medicine. 2017 Aug 4. pii: S1050-1738(17)30117-2.
- Pirkle JL, Schwartz J, Landis JR, Harlan WR. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. American Journal of Epidemiology. 1985 Feb;121(2):246-58.
- Solenkova NV, Newman JD, Berger JS, Thurston G, Hochman JS, Lamas GA. Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure. American Heart Journal. 2014 Dec;168(6):812-22.
- World Health Organization. The Public Health Impact of Chemicals: Knowns and Unknowns: Data addendum for 2019. 2021.
- Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, Burke TA, Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. American Journal of Epidemiology. 2005 Dec 1;162(11):1037-49; States JC, Srivastava S, Chen Y, Barchowsky A. Arsenic and cardiovascular disease. Toxicol Sci. 2009;107(2):312-323.
- Navas-Acien A, Selvin E, Sharrett AR, Calderon-Aranda E, Silbergeld E, Guallar E. Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004 Jun 29;109(25):3196-201.
- Tellez-Plaza M, Jones MR, Dominguez-Lucas A, Guallar E, Navas-Acien A. Cadmium exposure and clinical cardiovascular disease: a systematic review. Current Atherosclerosis Reports. 2013 Oct;15(10):356.
- Messner B, Knoflach M et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arteriosclerosis, Thrombosis, and Vasccular Biology. 2009 Sep;29(9):1392-8.
- Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016 Jan 12;133(2):187-225.
- Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016 Jan 12;133(2):187-225.
- Hilmers A, Hilmers DC, Dave J. Neighborhood disparities in access to healthy foods and their effects on environmental justice. American Journal of Public Health. 2012 Sep;102(9):1644-54.
- Chang R, Javed Z, Taha M, et al. Food insecurity and cardiovascular disease: Current trends and future directions. Am J Prev Cardiol. 2021;9:100303.
- Centers for Disease Control and Prevention. High Blood Pressure Risk Factors. May 14, 2024. Viewed June 10, 2024.
- Kivimäki M, Singh-Manoux A, Pentti J, et al. Physical inactivity, cardiometabolic disease, and risk of dementia: an individual-participant meta-analysis. BMJ. 2019;365:l1495.
- Kaplan A, Abidi E, Ghali R, Booz GW, Kobeissy F, Zouein FA. Functional, cellular, and molecular remodeling of the heart under influence of oxidative cigarette tobacco smoke. Oxidative Medicine and Cellular Longevity. 2017;2017:3759186.
- National Institutes of Health. NIH-funded studies show damaging effects of vaping, smoking on blood vessels. October 26, 2022. Viewed June 10, 2024.
- Rehm J, Roerecke M. Cardiovascular effects of alcohol consumption. Trends in Cardiovascular Medicine. 2017 Jun 10. pii: S1050-1738(17)30078-6; Zhou Y, Zheng J, Li S, Zhou T, Zhang P, Li HB. Alcoholic beverage consumption and chronic diseases. International Journal of Environmental Research and Public Health. 2016 May 24;13(6). pii: E522; Mukamal KJ, Rimm EB. Alcohol's effects on the risk for coronary heart disease. Alcohol Res Health. 2001;25(4):255-261; Gardner JD, Mouton AJ. Alcohol effects on cardiac function. Comprehensive Physiology. 2015 Apr;5(2):791-802.
- DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ. 1993 Mar 13;306(6879):688-91; Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. Journal of Periodontology. 1996 Oct;67(10 Suppl):1123-37.
- Siscovick DS, Schwartz SM et al. Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: the Cardiovascular Health Study. Circulation. 2000 Nov 7;102(19):2335-40.
- Chu C, Pollock LC, Selwyn PA. HIV-associated complications: a systems-based approach. American Family Physician. 2017 Aug 1;96(3):161-169; Ballocca F, D'Ascenzo F, Gili S, Grosso Marra W, Gaita F. Cardiovascular disease in patients with HIV. Trends in Cardiovascular Medicine. 2017 Jun 12. pii: S1050-1738(17)30089-0.
- Eberhardt N, Noval MG, Kaur R, et al. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels. Preprint. bioRxiv. 2023;2023.08.14.553245.
- Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic Research. 2002 Jan;52(1):1-23; Dimsdale JE. Psychological stress and cardiovascular disease. Journal of the American College of Cardiology. 2008 Apr 1; 51(13): 1237–1246; Bosma H, Peter R, Siegrist J, Marmot M. Two alternative job stress models and the risk of coronary heart disease. American Journal of Public Health. 1998 January; 88(1): 68–74.
- Cohen S, Doyle WJ, Baum A. Socioeconomic status is associated with stress hormones. Psychosomatic Medicine. 2006 May-Jun;68(3):414-20; Thomas KS, Nelesen RA, Ziegler MG, Bardwell WA, Dimsdale JE. Job strain, ethnicity, and sympathetic nervous system activity. Hypertension. 2004 Dec;44(6):891-6;Goosby BJ, Malone S, Richardson E, Cheadle JE, Williams D. Perceived discrimination and markers of cardiovascular risk among low-income African American youth. American Journal of Human Biology. 2015 Jul 8; 27(4): 546–552.
- Grundy SM, Benjamin et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999 Sep 7;100(10):1134-46.
- Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine. 2006 Oct;119(10):812-9.
- MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990 Mar 31;335(8692):765-74.
- American Society of Nephrology. The Kidney and Heart Disease Connection. Viewed June 11, 2024.
- National Heart, Lung and Blood Institute. What Is Metabolic Syndrome? June 22, 2016. Viewed June 11, 2024.
- Vartiainen E. The North Karelia Project: Cardiovascular disease prevention in Finland. Glob Cardiol Sci Pract. 2018;2018(2):13.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Schoonover H. A Fair Farm Bill for Public Health. Institute for Agriculture and Trade Policy. May 2007.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Public Health Law Center. Food Justice. Viewed June 11, 2024.
- Duffey KJ, Gordon-Larsen P et al. Food price and diet and health outcomes. Archives of Internal Medicine. 2010;170(5):420-426; Silver LD, Ng SW et al. Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: a before-and-after study. PLoS Medicine. 2017 Apr 18;14(4):e1002283.
- US Food and Drug Administration. FDA Cuts Trans Fat in Processed Foods. Marcy 17, 2017. Viewed August 25, 2017.
- Nicoll G, Zimring C. Effect of innovative building design on physical activity. Journal of Public Health Policy. 2009;30 Suppl 1:S111-23; Jancey JM, McGann S et al. Workplace building design and office-based workers' activity: a study of a natural experiment. Australian and New Zealand Journal of Public Health. 2016 Feb;40(1):78-82.
- Barnett DW, Barnett A et al. Built environmental correlates of older adults' total physical activity and walking: a systematic review and meta-analysis. International Journal of Behavorial Nutrition and Physical Activity. 2017 Aug 7;14(1):103; Bancroft C, Joshi S et al. Association of proximity and density of parks and objectively measured physical activity in the United States: a systematic review. Social Science and Medicine. 2015 Aug;138:22-30; Yen IH, Fandel Flood J, Thompson H, Anderson LA, Wong G. How design of places promotes or inhibits mobility of older adults: realist synthesis of 20 years of research. Journal of Aging and Health. 2014 Dec;26(8):1340-72.
- King DM, Jacobson SH. What is driving obesity? A review on the connections between obesity and motorized transportation. Current Obesity Reports. 2017 Mar;6(1):3-9; Yen IH, Fandel Flood J, Thompson H, Anderson LA, Wong G. How design of places promotes or inhibits mobility of older adults: realist synthesis of 20 years of research. Journal of Aging and Health. 2014 Dec;26(8):1340-72.
- Pucher J, Dill J, Handy S. Infrastructure, programs, and policies to increase bicycling: an international review. Preventive Medicine. 2010 Jan;50 Suppl 1:S106-25; Hirsch JA, Meyer KA et al. Municipal investment in off-road trails and changes in bicycle commuting in Minneapolis, Minnesota over 10 years: a longitudinal repeated cross-sectional study. International Journal of Behavioral Nutrition and Physical Activity. 2017 Feb 13;14(1):21.
- Labarthe DR, Goldstein LB et al. Evidence-based policy making: assessment of the American Heart Association's Strategic Policy Portfolio: a policy statement from the American Heart Association. Circulation. 2016 May 3;133(18):e615-53.
- Barnoya J, Glantz SA. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation. 2005 May 24;111(20):2684-98.
- Centers for Disease Control and Prevention. STATE System Smokefree Indoor Air Fact Sheet. February 28, 2024. Viewed June 11, 2024.
- Tan CE, Glantz SA. Association between smokefree legislation and hospitalizations for cardiac, cerebrovascular and respiratory diseases: a meta-analysis. Circulation. 2012 Oct 30; 126(18): 2177–2183.
- Akter S, Islam MR, Rahman MM, et al. Evaluation of Population-Level Tobacco Control Interventions and Health Outcomes: A Systematic Review and Meta-Analysis. JAMA Network Open. 2023;6(7):e2322341.
- Parry CD, Patra J, Rehm J. Alcohol consumption and non-communicable diseases: epidemiology and policy implications. Addiction. 2011 Oct;106(10):1718-24.
- American Heart Association. Facts: Danger in the Air Air Pollution and Cardiovascular Disease. Viewed August 13, 2017.
- Tan CE, Glantz SA. Guidance to Reduce the Cardiovascular Burden of Ambient Air Pollutants: A Policy Statement From the American Heart Association. Circulation. 2020 Nov 05; 142(23): e432–e447.
- US Environmental Protection Agency. Benefits and Costs of the Clean Air Act 1990-2020, the Second Prospective Study. May 15, 2024. Viewed June 11, 2024.
- Institute of Medicine (US) Committee on Preventing the Global Epidemic of Cardiovascular Disease: Meeting the Challenges in Developing Countries; Fuster V, Kelly BB, editors. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Washington (DC): National Academies Press (US); 2010; World Health Organization. New initiative launched to tackle cardiovascular disease, the world's number one killer. September 22, 2016. Viewed August 29, 2017; De Backer G, Ambrosioni E et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). European Heart Journal. 2003 Sep;21(17):1601–10.
- US Food and Drug Administration. Advice about Eating Fish. March 05, 2024. Viewed June 11, 2024; Also see state-specific advisories.
- Tang G, Wang D, Long J, Yang F, Si L. Meta-analysis of the association between whole grain intake and coronary heart disease risk. American Journal of Cardiology. 2015 Mar 1;115(5):625-9; Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. American Journal of Clinical Nutrition. 2014 Jul;100(1):278-88;Zheng J, Huang T, Yu Y, Hu X, Yang B, Li D. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutrition. 2012 Apr;15(4):725-37; Ravera A, Carubelli V et al. Nutrition and cardiovascular disease: finding the perfect recipe for cardiovascular health. Nutrients. 2016 Jun 14;8(6). pii: E363.
- Estruch R, Ros E et al. Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine. 2013 Apr 4;368(14):1279-90.
- US Department of Agriculture. Dietary Patterns and Risk of Cardiovascular Disease. Viewed June 11, 2024.
- Li XY, Cai XL, Bian PD, Hu LR. High salt intake and stroke: meta-analysis of the epidemiologic evidence. CNS Neuroscience & Therapeutics. 2012 Aug;18(8):691-701; Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. New England Journal of Medicine. 2006 Apr 13;354(15):1601-13; Xi B, Huang Y, Reilly KH et al. Sugar-sweetened beverages and risk of hypertension and CVD: a dose-response meta-analysis. British Journal of Nutrition. 2015 Mar 14;113(5):709-17.
- Carnethon MR. Physical activity and cardiovascular disease: how much is enough? American Journal of Lifestyle Medicine. 2009 Jul;3(1 Suppl):44S-49S; Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. American Journal of Preventive Medicine. 2004 Jun;26(5):407-18.
- World Health Organization. Global recommendations on physical activity for health. 2010. Viewed June 11, 2024; Centers for Disease Control and Prevention. Physical activity basics: How much physical activity do you need? March 26, 2024. Viewed June 11, 2024; American Heart Association. American Heart Association recommendations for physical activity in adults and kids. January 19, 2024. Viewed June 11, 2024.
- Brown N, Luckett T, Davidson PM, DiGiacomo M. Family-focussed interventions to reduce harm from smoking in primary school-aged children: a systematic review of evaluative studies. Preventive Medicine. 2017 Aug;101:117-125.
- American Heart Association. Is drinking alcohol part of a healthy lifestyle? December 30, 2019. Viewed June 11, 2024.
- Jackson DB, Testa A, Woodward KP, Qureshi F, Ganson KT, Nagata JM. Adverse Childhood Experiences and Cardiovascular Risk among Young Adults: Findings from the 2019 Behavioral Risk Factor Surveillance System. Int J Environ Res Public Health. 2022;19(18):11710.
- Berkman LF, Kawachi I, editors. Social Epidemiology. New York: Oxford University Press; 2000; Hardy R, Lawlor DA, Kuh D. A life course approach to cardiovascular aging. Future Cardiology. 2015;11(1):101-13; Aboderin I, Kalache A, Ben-Shlomo Y, Lynch JW, Yajnik CS, Kuh D, Yach D. Life course perspectives on coronary heart disease, stroke and diabetes: key issues and implications for policy and research. 2001 Geneva, World Health Organization. 2002; Halfon N, Larson K, Lu M, Tullis E, Russ S. Lifecourse health development: past, present and future. Maternal and Child Health Journal. 2014 Feb;18(2):344-65; Hanson MA, Cooper C, Aihie Sayer A, Eendebak RJ, Clough GF, Beard JR. Developmental aspects of a life course approach to healthy ageing. Journal of Physiology. 2016 Apr 15;594(8):2147-60.